Pàgina inicial > Resultats de la cerca: Appelbaum, Frederick
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
33 p, 2.0 MB Diagnosis and management of AML in adults : 2022 recommendations from an international expert panel on behalf of the ELN / Döhner, Hartmut (Ulm University Hospital. Department of Internal Medicine III) ; Wei, Andrew H. (Peter MacCallum Cancer Centre. Royal Melbourne Hospital and University of Melbourne. Department of Haematology) ; Appelbaum, Frederick (University of Washington. Fred Hutchinson Cancer Research Center) ; Craddock, Charles (Centre for Clinical Haematology. Queen Elizabeth Hospital. University of Birminham) ; DiNardo, Courtney D. (The University of Texas MD Anderson Cancer Center. Department of Leukemia) ; Dombret, Hervé (Saint-Louis Institute for Research. Université de Paris. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris. Department of Hematology) ; Ebert, Benjamin L. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Fenaux, Pierre (Service d'Hématologie Séniors. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris) ; Godley, Lucy A. (The University of Chicago. Section of Hematology/Oncology. Department of Medicine) ; Hasserjian, Robert P (Massachusetts General Hospital) ; Larson, Richard A (University of Chicago. Department of Medicine and Comprehensive Cancer Center) ; Levine, Ross L. (Memorial Sloan Kettering Cancer Center. Human Oncology and Pathogenesis Program and Leukemia Service. Department of Medicine) ; Miyazaki, Yasushi (Atomic Bomb Disease Institute. Nagasaki University. Department of Hematology) ; Niederwieser, Dietger (University of Leipzig) ; Ossenkoppele, Gert (Department of Haematology. Amsterdam UMC. Location VU University Medical Center) ; Röllig, Christoph (Department of Internal Medicine I. University Hospital Carl Gustav Carus TU Dresden) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Stein, Eytan M. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tallman, Martin S. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tien, Hwei-Fang F. (Division of Hematology. Department of Internal Medicine. National Taiwan University Hospital) ; Wang, Jianxiang (Institute of Hematology and Blood Diseases Hospital. Chinese Academy of Medical Sciences & Peking Union Medical College) ; Wierzbowska, Agnieszka (Department of Hematology. Medical University of Lodz) ; Löwenberg, Bob (Department of Hematology. Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute)
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. [...]
2022 - 10.1182/blood.2022016867
Blood, Vol. 140 Núm. 12 (september 2022) , p. 1345-1377  
Registre complet - Creative Commons
2.
1.2 MB Molecular landscape and prognostic impact of FLT3 -ITD insertion site in acute myeloid leukemia : RATIFY study results / Rücker, Frank G. (University Hospital of Ulm (Alemanya)) ; Du, Ling (Novartis Pharmaceuticals, Cambridge) ; Luck, Tamara J. (Charité University, Berlin) ; Benner, Axel (German Cancer Research Center, Heidelberg) ; Krzykalla, Julia (German Cancer Research Center, Heidelberg) ; Gathmann, Insa (Novartis Pharmaceuticals, Basel) ; Voso, Maria Teresa (Università di Roma "Tor Vergata", Rome) ; Amadori, Sergio (Università di Roma "Tor Vergata", Rome) ; Prior, Thomas W. (The Ohio State University Comprehensive Cancer Center, Columbus) ; Brandwein, Joseph M. (University of Alberta, Edmonton) ; Appelbaum, Frederick (Fred Hutchinson Cancer Research Center, Seattle) ; Medeiros, Bruno (Stanford University) ; Tallman, Martin S. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York) ; Savoie, Lynn (University of Calgary, Calgary) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Pallaud, Celine (Novartis Pharmaceuticals, Basel) ; Sanz, Miguel A.. (Hospital Universitari i Politècnic La Fe (València)) ; Jansen, Joop H. (Radboud University Medical Center, Nijmegen) ; Niederwieser, Dietger (Hematology and Oncology, University of Leipzig, Leipzig) ; Fischer, Thomas (Otto-von-Guericke University Magdeburg, Magdeburg) ; Ehninger, Gerhard (Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden) ; Heuser, Michael (Hannover Medical School, Hannover) ; Ganser, Arnold (Oncology and Stem Cell Transplantation, Hannover) ; Bullinger, Lars (Charité University, Berlin) ; Larson, Richard A. (University of Chicago, Chicago) ; Bloomfield, Clara D. (The Ohio State University Comprehensive Cancer Center, Columbus) ; Stone, Richard M. (Dana-Farber/Partners CancerCare, Boston) ; Döhner, Hartmut (University Hospital of Ulm (Alemanya)) ; Thiede, Christian (Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden) ; Döhner, Konstanze (University Hospital of Ulm (Alemanya)) ; Universitat Autònoma de Barcelona
In acute myeloid leukemia (AML) internal tandem duplications of the FLT3 gene (FLT3- ITD) are associated with poor prognosis. Retrospectively, we investigated the prognostic and predictive impact of FLT3 -ITD insertion site (IS) in 452 patients randomized within the RATIFY trial, which evaluated midostaurin additionally to intensive chemotherapy. [...]
2021 - 10.1038/s41375-021-01323-0
Leukemia, Vol. 36 (july 2021) , p. 90-99  
Registre complet - Creative Commons
3.
10 p, 1.3 MB Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission : analysis from CALGB 10403 and the CIBMTR / Wieduwilt, Matthew J. (University of California) ; Stock, Wendy (University of Chicago Medicine) ; Advani, Anjali (Cleveland Clinic) ; Luger, Selina (University of Pennsylvania Medical Center) ; Larson, Richard A. (University of Chicago Medicine) ; Tallman, Martin (Memorial Sloan Kettering Cancer Center. Leukemia Service, Department of Medicine) ; Appelbaum, Frederick (Fred Hutchinson Cancer Research Center) ; Zhang, Mei-Jie (Medical College of Wisconsin. Division of Biostatistics) ; Bo-Subait, Khalid (Medical College of Wisconsin) ; Wang, Hai-Lin (Medical College of Wisconsin) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Dholaria, Bhagirathbhai (Vanderbilt University Medical Center) ; Eapen, Mary (Medical College of Wisconsin) ; Hamadani, Mehdi (Medical College of Wisconsin) ; Jamy, Omer (University of Alabama at Birmingham) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Pulsipher, Michael (Children's Hospital Los Angeles Cancer) ; Ritchie, David (Peter MacCallum Cancer Centre) ; Rizzieri, David (Duke University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Barba, Pere (Hospital Universitari Vall d'Hebron) ; Sandmaier, Brenda M. (Fred Hutchinson Cancer Research Center) ; de Lima, Marcos (University Hospitals Case Medical Center) ; Kebriaei, Partow (The University of Texas MD Anderson Cancer Center) ; Litzow, Mark (Mayo Clinic.) ; Saber, Wael (Medical College of Wisconsin) ; Weisdorf, Daniel (University of Minnesota) ; Universitat Autònoma de Barcelona
Optimal post-remission therapy for adolescents and young adults (AYAs) with Ph-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is not established. We compared overall survival (OS), disease-free survival (DFS), relapse, and non-relapse mortality (NRM) for patients receiving post-remission therapy on CALGB 10403 to a cohort undergoing myeloablative (MA) allogeneic hematopoietic cell transplantation (HCT) in CR1. [...]
2021 - 10.1038/s41375-021-01213-5
Leukemia, Vol. 35 (march 2021) , p. 2076-2085  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
2 Appelbaum, F.R.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem